Efficacy of neoadjuvant endocrine therapy compared with neoadjuvant chemotherapy in pre-menopausal patients with oestrogen receptor-positive and HER2-negative, lymph node-positive breast cancer

INTRODUCTION: Neoadjuvant endocrine therapy (NET) has demonstrated efficacy in post-menopausal patients with hormone-responsive breast cancer. This trial was designed to compare the efficacy of neoadjuvant chemotherapy (NCT) with NET in pre-menopausal breast cancer. PATIENTS AND METHODS: In this pro...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Hee Jeong, Noh, Woo Chul, Lee, Eun Sook, Jung, Yong Sik, Kim, Lee Su, Han, Wonshik, Nam, Seok Jin, Gong, Gyung -Yub, Kim, Hwa Jung, Ahn, Sei Hyun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7251809/
https://www.ncbi.nlm.nih.gov/pubmed/32460816
http://dx.doi.org/10.1186/s13058-020-01288-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7251809/
https://www.ncbi.nlm.nih.gov/pubmed/32460816
http://dx.doi.org/10.1186/s13058-020-01288-5

Ejemplares similares